Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ArvinasLigand PharmaceuticalsAkcea TherapeuticsPPDAimmune Therapeutics
SymbolNASDAQ:ARVNNASDAQ:LGNDNASDAQ:AKCANASDAQ:SDGRNASDAQ:AIMT
Price Information
Current Price$39.36$66.79$13.31$40.23$13.98
52 Week RangeBuyBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$50.80$164.80$34.67$50.00$43.45
% Upside from Price Target29.07% upside146.74% upside160.46% upside24.29% upside210.83% upside
Trade Information
Market Cap$1.61 billion$1.20 billion$1.46 billion$2.53 billion$904.94 million
Beta2.441.181.29N/A0.38
Average Volume425,371798,532317,8651,188,5192,072,357
Sales & Book Value
Annual Revenue$42.98 million$120.28 million$488.54 millionN/AN/A
Price / Sales35.799.162.75N/AN/A
CashflowN/A$5.48 per share$0.47 per shareN/AN/A
Price / CashN/A12.1928.29N/AN/A
Book Value$6.72 per share$43.68 per share$5.78 per shareN/A$1.66 per share
Price / Book5.861.532.30N/AN/A
Profitability
Net Income$-70,290,000.00$629.30 million$40.77 millionN/A$-248,500,000.00
EPS($2.13)$2.11$0.48N/A($3.97)
Trailing P/E RatioN/A2.2828.940.00N/A
Forward P/E RatioN/A24.11N/AN/AN/A
P/E GrowthN/A$2.14N/AN/AN/A
Net Margins-163.56%523.19%8.35%N/AN/A
Return on Equity (ROE)-30.16%4.34%10.03%N/A-138.44%
Return on Assets (ROA)-20.99%2.40%8.70%N/A-90.72%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%0.85%0.03%N/A0.50%
Current Ratio8.86%66.09%11.83%N/A3.14%
Quick Ratio8.86%65.66%11.62%N/A3.14%
Ownership Information
Institutional Ownership Percentage77.22%N/A20.65%N/A74.69%
Insider Ownership Percentage31.77%8.40%1.50%N/A13.75%
Miscellaneous
Employees83116248392228
Shares Outstanding39.08 million16.50 million101.07 million61.45 million62.67 million
Next Earnings Date5/13/2020 (Estimated)5/7/2020 (Estimated)5/13/2020 (Estimated)N/A5/13/2020 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel